Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Pediatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
INTERVENTIONAL
Inicio: 1 de sept de 2000
ID: NCT00044278
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
INTERVENTIONAL
Inicio: 17 de dic de 2018
ID: NCT03773978
Completado
ClinicalTrials.gov
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
OBSERVATIONAL
Inicio: 1 de jun de 2009
ID: NCT01163240
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Open-label Trial, to Investigate Pharmacokinetics, Safety, Tolerability and Antiviral Activity of TMC114/Rtv b.i.d in Treatment-Experienced HIV-1 Infected Children and Adolescents
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00355524
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy
INTERVENTIONAL
Inicio: 9 de jun de 2011
ID: NCT01311648
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondansetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients.
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01395901
Completado
ClinicalTrials.gov
FIRST BREATH: Neonatal Resuscitation in Developing Countries
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00136708
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
INTERVENTIONAL
Inicio: 11 de jul de 2022
ID: NCT04965636
Aún no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder
INTERVENTIONAL
Inicio: 27 de feb de 2026
ID: NCT07284745
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
INTERVENTIONAL
Inicio: 21 de jun de 2023
ID: NCT05889182
Completado
Fase 3
ClinicalTrials.gov
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
INTERVENTIONAL
Inicio: 27 de ene de 2021
ID: NCT04652726
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled Trial With an Open-label Extension to Assess the Pharmacokinetics, Safety, and Efficacy of Empagliflozin Tablets in Paediatric Patients With Chronic Kidney Disease (EMPA-KIDNEY® Kids)
INTERVENTIONAL
Inicio: 9 de dic de 2025
ID: NCT07107945
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis
INTERVENTIONAL
Inicio: 13 de ago de 2018
ID: NCT03569293
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC or HEC
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01442376
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Dose-Response of Ramipril for the Treatment of Hypertension in Children and Adolescents
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00389519
Completado
Fase 3
ClinicalTrials.gov
A Two Part, Double-blind, Randomized, Placebo-controlled and Open-label Study to Investigate the Efficacy, Safety and Tolerability of Eltrombopag, a Thrombopoietin Receptor Agonist, in Pediatric Patients With Previously Treated Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP). PETIT2: Eltrombopag in PEdiatric Patients With Thrombocytopenia From ITP
INTERVENTIONAL
Inicio: 1 de mar de 2012
ID: NCT01520909
Terminado
Fase 3
ClinicalTrials.gov
A Double-blind, Placebo-controlled, Adaptive, Phase 2/3 Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of INM004 in Pediatric Patients With Shiga Toxin-positive Bloody Diarrhea for Prevention of Hemolytic Uremic Syndrome
INTERVENTIONAL
Inicio: 17 de jul de 2019
ID: NCT04132375
Completado
Fase 2
ClinicalTrials.gov
A Prospective, Randomized, Open Label, Multi-center Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist or LMWH in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention
INTERVENTIONAL
Inicio: 19 de ene de 2017
ID: NCT02981472
Completado
Fase 4
ClinicalTrials.gov
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
INTERVENTIONAL
Inicio: 17 de nov de 2011
ID: NCT01462344
Completado
Fase 1
ClinicalTrials.gov
A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Systemic Juvenile Idiopathic Arthritis
INTERVENTIONAL
Inicio: 15 de ago de 2013
ID: NCT01904292
Anterior
1
...
18
19
20
...
434
Siguiente
Filtros